Pulsion Medical Systems SE / Key word(s): Miscellaneous 14.08.2014 19:29 Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Pulsion Medical Systems SE: General Meeting approves domination and profit and loss transfer agreement Feldkirchen, 14.08.2014 - The extraordinary general meeting of Pulsion Medical Systems SE (ISIN: DE0005487904 / WKN 548790, "Pulsion") today approved the domination and profit and loss transfer agreement dated July 3rd, 2014 between MAQUET Medical Systems AG (an indirect subsidiary of Getinge AB, Sweden) as the controlling entity and Pulsion Medical Systems SE as the controlled entity according to sec. 293 para. 1 of the German Stock Corporation Act ("AktG"). The domination and profit and loss transfer agreement provides for a guaranteed dividend respectively an annual recurring compensation payment for the shareholders of Pulsion pursuant to sec. 304 AktG in the gross amount of 1.02 EUR (0.86 EUR net based on the current taxation) per share and a cash compensation pursuant to sec. 305 AktG in the amount of 17.03 EUR per share. The domination and profit and loss transfer agreement will be valid upon its registration with the commercial register of Pulsion. Contact: Investor Relations PULSION Medical Systems SE Ralph Schäfer Director Legal Affairs Tel.: +49 (0)89 / 459914 211 Fax: +49 (0)89 / 459914 481 E-mail: schaefer@pulsion.com 14.08.2014 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Pulsion Medical Systems SE Hans- Riedl- StraÃe 21 85622 Feldkirchen Germany Phone: +49 (0)89 4599 14-0 Fax: +49 (0)89 4599 14-18 E-mail: info@pulsion.com Internet: www.pulsion.com ISIN: DE0005487904 WKN: 548790 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: Pulsion Medical Systems SE: General Meeting approves domination and profit and loss transfer agreement
| Source: EQS Group AG